长非编码RNA在胃肠癌细胞代谢重编程中的作用
Kang Wang1,2, Yan Lu1, Haibin Li1,2
1Department of Gastrointestinal Surgery, Shunde Hospital, Southern Medical University, The First People's Hospital of Shunde Foshan), Shunde, Foshan, 528300, Guangdong, China.
Cancer cell international
|January 6, 2024
概括
长非编码RNAs (lncRNAs) 重编程癌细胞代谢并影响瘤微环境. 本综述探讨了lncRNA在胃肠道瘤代谢和免疫中的作用,并确定了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 代谢重编程是癌症的标志,使瘤细胞能够满足增加的生物合成需求.
- 癌细胞在关键的代谢途径中表现出显著的变化,包括糖解,氧化酸化和氨基酸代谢.
- 长非编码RNAs (lncRNAs) 越来越被认为是癌症中这些代谢转变的关键调节者.
研究的目的:
- 审查 lncRNAs 在癌症中调解代谢重编程的机制.
- 阐明lncRNAs在调节胃肠道瘤中的葡萄糖,脂质和氨基酸代谢中的作用.
- 探索lncRNAs,瘤免疫和胃肠道癌症的潜在治疗策略之间的联系.
主要方法:
- 关于 lncRNAs 和癌症代谢的最新研究的文献综述.
- 对代谢途径和酶的lncRNA介导调节的分析.
- 检查lncRNA参与瘤微环境和耐药性的研究.
主要成果:
- lncRNAs通过转录,翻译和翻译后修改来调节癌细胞代谢.
- lncRNAs影响关键的代谢途径,如糖解,氧化酸化和氨基酸代谢.
- lncRNAs影响瘤的增殖,迁移,耐药性,以及瘤的免疫微环境.
结论:
- lncRNAs是胃肠道瘤中代谢重编程的关键调节者.
- 了解 lncRNA 功能,可以了解新的治疗点和治疗胃肠道癌症的药物开发.
- 通过lncRNA调节新陈代谢和免疫,为癌症治疗提供了有前途的途径.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


